Cargando…

Differential Effects of Genetically Determined Cholesterol Efflux Capacity on Coronary Artery Disease and Ischemic Stroke

BACKGROUND: Observational studies indicated that cholesterol efflux capacity (CEC) of high-density lipoprotein (HDL) is inversely associated with cardiovascular events, independently of the HDL cholesterol concentration. The aim of the study is to examine the casual relevance of CEC for coronary art...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Aoming, Wang, Mengxing, Chen, Weiqi, Yan, Hongyi, Xiang, Xianglong, Pan, Yuesong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289203/
https://www.ncbi.nlm.nih.gov/pubmed/35859596
http://dx.doi.org/10.3389/fcvm.2022.891148
_version_ 1784748611945365504
author Jin, Aoming
Wang, Mengxing
Chen, Weiqi
Yan, Hongyi
Xiang, Xianglong
Pan, Yuesong
author_facet Jin, Aoming
Wang, Mengxing
Chen, Weiqi
Yan, Hongyi
Xiang, Xianglong
Pan, Yuesong
author_sort Jin, Aoming
collection PubMed
description BACKGROUND: Observational studies indicated that cholesterol efflux capacity (CEC) of high-density lipoprotein (HDL) is inversely associated with cardiovascular events, independently of the HDL cholesterol concentration. The aim of the study is to examine the casual relevance of CEC for coronary artery disease (CAD) and myocardial infarction (MI), and compare it with that for ischemic stroke and its subtypes using a Mendelian randomization approach. METHODS: We performed a 2-sample Mendelian randomization to estimate the casual relationship of CEC with the risk of CAD, MI, and ischemic stroke. A CEC-related genetic variant (rs141622900) and other five genetic variants were used as the instrumental variables. Association of genetic variants with CAD were estimated in a GWAS involving 60,801 CAD cases and 123,504 controls. They were then compared with the associations of these variants with ischemic stroke and its subtypes (large vessel, small vessel, and cardioembolic) involving 40,585 ischemic stroke cases and 406,111 controls. RESULTS: Using the SNP of rs141622900 as the instrument, a 1-SD increase in CEC was associated with 45% lower risk for CAD (odds ratio [OR] 0.55, 95% confidence interval [CI] 0.44–0.69, p < 0.001) and 33% lower risk for MI (odds ratio [OR] 0.67, 95% CI 0.52–0.87, p = 0.002). By contrast, the causal effect of CEC was much weaker for ischemic stroke (odds ratio [OR] 0.79, 95% CI 0.64–0.97, p = 0.02; p for heterogeneity = 0.03) and, in particular, for cardioembolic stroke (p for heterogeneity = 0.006) when compared with that for CAD. Results using five genetic variants as the instrument also indicated consistently weaker effects on ischemic stroke than on CAD. CONCLUSION: Genetic predicted higher CEC may be associated with decreased risk of CAD. However, the casual association of CEC with ischemic stroke and specific subtypes would need to be validated in further Mendelian randomization studies.
format Online
Article
Text
id pubmed-9289203
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-92892032022-07-19 Differential Effects of Genetically Determined Cholesterol Efflux Capacity on Coronary Artery Disease and Ischemic Stroke Jin, Aoming Wang, Mengxing Chen, Weiqi Yan, Hongyi Xiang, Xianglong Pan, Yuesong Front Cardiovasc Med Cardiovascular Medicine BACKGROUND: Observational studies indicated that cholesterol efflux capacity (CEC) of high-density lipoprotein (HDL) is inversely associated with cardiovascular events, independently of the HDL cholesterol concentration. The aim of the study is to examine the casual relevance of CEC for coronary artery disease (CAD) and myocardial infarction (MI), and compare it with that for ischemic stroke and its subtypes using a Mendelian randomization approach. METHODS: We performed a 2-sample Mendelian randomization to estimate the casual relationship of CEC with the risk of CAD, MI, and ischemic stroke. A CEC-related genetic variant (rs141622900) and other five genetic variants were used as the instrumental variables. Association of genetic variants with CAD were estimated in a GWAS involving 60,801 CAD cases and 123,504 controls. They were then compared with the associations of these variants with ischemic stroke and its subtypes (large vessel, small vessel, and cardioembolic) involving 40,585 ischemic stroke cases and 406,111 controls. RESULTS: Using the SNP of rs141622900 as the instrument, a 1-SD increase in CEC was associated with 45% lower risk for CAD (odds ratio [OR] 0.55, 95% confidence interval [CI] 0.44–0.69, p < 0.001) and 33% lower risk for MI (odds ratio [OR] 0.67, 95% CI 0.52–0.87, p = 0.002). By contrast, the causal effect of CEC was much weaker for ischemic stroke (odds ratio [OR] 0.79, 95% CI 0.64–0.97, p = 0.02; p for heterogeneity = 0.03) and, in particular, for cardioembolic stroke (p for heterogeneity = 0.006) when compared with that for CAD. Results using five genetic variants as the instrument also indicated consistently weaker effects on ischemic stroke than on CAD. CONCLUSION: Genetic predicted higher CEC may be associated with decreased risk of CAD. However, the casual association of CEC with ischemic stroke and specific subtypes would need to be validated in further Mendelian randomization studies. Frontiers Media S.A. 2022-07-04 /pmc/articles/PMC9289203/ /pubmed/35859596 http://dx.doi.org/10.3389/fcvm.2022.891148 Text en Copyright © 2022 Jin, Wang, Chen, Yan, Xiang and Pan. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Jin, Aoming
Wang, Mengxing
Chen, Weiqi
Yan, Hongyi
Xiang, Xianglong
Pan, Yuesong
Differential Effects of Genetically Determined Cholesterol Efflux Capacity on Coronary Artery Disease and Ischemic Stroke
title Differential Effects of Genetically Determined Cholesterol Efflux Capacity on Coronary Artery Disease and Ischemic Stroke
title_full Differential Effects of Genetically Determined Cholesterol Efflux Capacity on Coronary Artery Disease and Ischemic Stroke
title_fullStr Differential Effects of Genetically Determined Cholesterol Efflux Capacity on Coronary Artery Disease and Ischemic Stroke
title_full_unstemmed Differential Effects of Genetically Determined Cholesterol Efflux Capacity on Coronary Artery Disease and Ischemic Stroke
title_short Differential Effects of Genetically Determined Cholesterol Efflux Capacity on Coronary Artery Disease and Ischemic Stroke
title_sort differential effects of genetically determined cholesterol efflux capacity on coronary artery disease and ischemic stroke
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289203/
https://www.ncbi.nlm.nih.gov/pubmed/35859596
http://dx.doi.org/10.3389/fcvm.2022.891148
work_keys_str_mv AT jinaoming differentialeffectsofgeneticallydeterminedcholesteroleffluxcapacityoncoronaryarterydiseaseandischemicstroke
AT wangmengxing differentialeffectsofgeneticallydeterminedcholesteroleffluxcapacityoncoronaryarterydiseaseandischemicstroke
AT chenweiqi differentialeffectsofgeneticallydeterminedcholesteroleffluxcapacityoncoronaryarterydiseaseandischemicstroke
AT yanhongyi differentialeffectsofgeneticallydeterminedcholesteroleffluxcapacityoncoronaryarterydiseaseandischemicstroke
AT xiangxianglong differentialeffectsofgeneticallydeterminedcholesteroleffluxcapacityoncoronaryarterydiseaseandischemicstroke
AT panyuesong differentialeffectsofgeneticallydeterminedcholesteroleffluxcapacityoncoronaryarterydiseaseandischemicstroke